Skip to main content
. 2014 Sep 12;9(9):e107584. doi: 10.1371/journal.pone.0107584

Table 3. Performance of NAFLD screening scores: development and external validation datasets.

Method, by Dataset High risk(%) Sensitivity Specificity PPV NPV Positive Negative Youden AUC* RequiresClinician’sInput?
LR LR Index
Development dataset (N = 15676)
Comprehensive score (male) ≥40 43 69 84 82 72 4.46 0.36 54 0.86 Yes
Comprehensive score (female) ≥40 29 72 89 73 88 6.50 0.31 61 0.90 Yes
Simple score (male) ≥8 58 80 67 72 76 2.41 0.29 47 0.82 No
Simple score (female) ≥8 36 77 81 63 89 4.09 0.28 58 0.87 No
Park’s index* 41 72 81 73 80 3.84 0.35 53 0.83 Yes
Hepatic steatosis index* 20 41 95 85 70 7.91 0.62 36 0.85 Yes
Fatty liver index* 12 26 98 89 65 11.09 0.76 23 0.86 Yes
NAFLD liver fat score* , 19 37 94 81 68 6.26 0.67 31 0.77 Yes
External validation dataset (N = 66868)
Comprehensive score (male) ≥40 37 67 85 76 77 4.32 0.39 52 0.85 Yes
Comprehensive score (female) ≥40 20 71 88 49 95 6.13 0.33 59 0.89 Yes
Simple score (male) ≥8 49 75 71 66 79 2.53 0.36 45 0.80 No
Simple score (female) ≥8 22 68 85 42 94 4.57 0.38 54 0.85 No
Park’s index* 38 76 78 59 89 3.44 0.30 54 0.84 Yes
Hepatic steatosis index* 21 52 92 74 82 6.56 0.52 44 0.86 Yes
Fatty liver index* 11 30 97 82 76 10.77 0.72 27 0.87 Yes
NAFLD liver fat score* , 16 40 94 75 79 6.96 0.63 35 0.82 Yes

*The definition of the above risk models for NAFLD.

Park’s index for NAFLD: index ≥3, in which Park’s index = (ALT/AST ratio >1.5)×1+(γ-glutamyl-transferase >50)×1+(triglycerides >150)×1+(23≤ BMI <25)×2+(25≤ BMI)×3.

Hepatic steatosis index (HSI): HSI >36 for high-risk and <30 for no NAFLD, in which HSI = 8×ALT/AST ratio+BMI (+2, if diabetes;+2, if female).

Fatty liver index (FLI): FLI ≥60 for high-risk and <30 for no NAFLD, in which FLI = 1/(1+exp(−x))×100, where x = 0.953×loge (triglycerides)+0.139×BMI+0.718×loge (γ-glutamyl-transferase)+0.053×WC −15.745.

NAFLD liver fat score: score ≥−0.640, in which NAFLD liver fat score = −2.89+1.18×metabolic syndrome+0.45×diabetes+0.15×fasting insulin+0.04×AST+0.94×AST/ALT ratio.

After imputing the missing data for alcohol consumption and menopausal status.

After imputing the missing data of fasting insulin levels.